Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment
NCT01666431
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Squamous Cell Carcinoma
Interventions
DRUG:
Lapatinib
Sponsor
University of Zurich